Introduction
============

Secoisolariciresinol (SECO) diglucoside (SDG) is one of the essential dietary lignans, found in high levels in flaxseed ([@B23]). Along with α-linolenic acid, lignans, mainly SDG, have made flaxseed derivatives (flax oil and lignan extracts) important sources of functional food or nutraceutical ingredients ([@B33]; [@B55]). Although flaxseed possesses beneficial fatty acid composition and high fiber content, the phytoestrogenic, anticarcinogenic, and antiatherogenic effects have been attributed to its lignan content ([@B48]; [@B23]; [@B90]; [@B8]). Moreover, ingested SDG is converted into mammalian lignans, enterodiol (END) and enterolactone (ENL), by the gut microflora enzymes ([@B8]; [@B79]), and these mammalian lignans have been found to negatively correlate with the incidence of breast cancer ([@B35]; [@B23]; [@B2]).

SDG was isolated from flaxseed by [@B3], and in contrast to free lignans found in most plants, SDG is present in an oligomeric structure, referred to as lignan macromolecule ([@B3]; [@B48]; [@B79]). Flaxseed is the richest source of SDG; however, it also contains small amounts of other lignans, namely pinoresinol, lariciresinol, and matairesinol ([@B48]; [@B79]; [@B2]). SDG has two enantiomers (+) and (-), whose distribution varies in different *Linum* species. A study showed that one of the two enantiomers of SDG was predominant in the seed, except for some species, such as *L. elegans* and *L. flavum*, that contained both enantiomers ([@B48]). The (+) enantiomer was predominant in *L. usitatissimum* (flaxseed); however, the concentration of SDG varied in different varieties ([@B48]). Although new technologies, such as *in vitro* morphogenesis ([@B39]), transformed hairy root culture ([@B25]) and other biotechnological systems ([@B38]), are being used to increase the content of lignans in *Linum* species, the difference in varieties still affects the health beneficial properties of the lignan fractions ([@B17]). In this review, we highlight studies on the biosynthesis of SDG in flaxseed and its health benefits, as well as the genes involved in this metabolic pathway.

Lignans From Flaxseed
=====================

The main lignan in flaxseed is SDG, which is found in a linked macromolecular structure (lignan macromolecule) ([@B48]; [@B81]; [@B79]; [@B84]; [@B76]). In flaxseed, the hull fraction contains higher amounts of lignans than that in the whole seeds ([@B51]; [@B43]; [@B91]; [@B80]), suggesting that lignans are mainly biosynthesized in the hull.

Biosynthetic Pathways of Flaxseed Lignans
=========================================

The biosynthesis of lignans in flaxseed involves the following pathways ([@B85]; [@B30]; [@B79]; [@B29]) (KEGG PATHWAY: map01061):

-   the phenylpropanoid pathway

-   stereospecific coupling by dirigent proteins

-   biosynthesis of dibenzylbutane lignans

-   glycosylation of lignans into SDG

The Phenylpropanoid Pathway
===========================

The phenylpropanoid pathway is responsible for the formation of the C6-C3 basic unit of lignans. The first step of this pathway is the deamination of phenylalanine by phenylalanine-ammonia lyase producing cinnamic acid ([@B79]). Cinnamic acid is oxidized to *p-*coumaric acid, which can further be oxidized to caffeic acid. Then, caffeic acid can be metabolized into ferulic acid by caffeic acid *O-*methyltransferase. Ferulic acid is converted into its coenzyme A-activated form, feruloyl-CoA by 4-coumarate:CoA ligase. Feruloyl-CoA is further reduced to coniferaldehyde by cinnamoyl-CoA reductase and finally into coniferyl alcohol by cinnamyl alcohol dehydrogenase and sinapyl alcohol dehydrogenase ([@B6]).

Stereospecific Coupling by Dirigent Proteins
============================================

The formation of a lignan via stereoselective coupling of two coniferyl alcohols was first studied in *Forsythia* species in 1990, when two phenylpropanoid monomers, coniferyl alcohols, were oxidized in the presence of the insoluble fraction of *Forsythia* stem, yielding pinoresinol ([@B86]). Later, a protein purified from the insoluble fraction of *Forsythia* stem was used to catalyze the dimerization of coniferyl alcohols only in the presence of an oxidase and was called a dirigent protein since it is not involved in the reaction ([@B15]; [@B11]). The discovery of the dirigent protein ([@B15]; [@B14]) allowed the understanding of phenolic radical coupling: an oxidase forms two radicals from the alcohols, and the dirigent protein aligns the radicals, followed by the stereoselective radical coupling reaction. Of all the C6-C3 units formed by the phenylpropanoid pathway, only coniferyl alcohol is dimerized in a stereospecific way ([@B15]).

After the formation of pinoresinol, lignan biosynthesis can proceed by two different pathways. In the first pathway, the furan structures are reduced, and dibenzylbutane lignans, such as SECO, are formed. In the second pathway, the furan structures remain intact, and methylenedioxy bridged furanofuran lignans, such as sesamin, are formed ([@B81]; [@B79]; [@B76]). In flaxseed, the biosynthesis follows the first pathway.

Biosynthesis of Dibenzylbutane Lignans
======================================

Pinoresinol is subsequently converted into lariciresinol and secoisolariciresinol by a bifunctional NADPH-dependent pinoresinol/lariciresinol reductase (PLR) ([@B22]). PLRs completely convert pinoresinol into lariciresinol first before lariciresinol is converted to SECO ([@B87]; [@B32]). The other lignan found in flaxseed, matairesinol, is formed by secoisolariciresinol dehydrogenase (SDH) ([@B22]; [@B93]; [@B85]; [@B79]). The main lignan in flaxseed is found in a glycosylated form, indicating an additional role of the genes responsible for the glycosylation of SECO. These genes are UDPG: glucosyltransferases (GTs), which glycosylate the C-9 and C-9′ hydroxyl positions of SECO ([@B22]).

Glycosylation of Seco
=====================

In flaxseed, this represents the last step in the biosynthesis of SDG. Glycosylation is catalyzed by GTs, which are highly divergent, polyphyletic, and belong to a multigene family found in all living organisms ([@B42]; [@B4]).

Several studies have shown the presence of plant GTs ([@B74]; [@B88]; [@B7]). In plants, they belong to family 1 GTs, known as uridine GTs (UGTs) ([@B7]; [@B21]). UGTs catalyze the transfer of UDP-activated sugars to specific acceptor molecules ([@B36]; [@B74]; [@B92]). In plants, they are characterized by a unique, well-conserved PSPG (plant secondary product glycosyltransferases) box, formed by a sequence of 44-amino acid residues ([@B54]; [@B26]; [@B4]) and a catalytic mechanism that inverts the anomeric configuration of the transferred sugar ([@B88]; [@B4]).

In flax, 137 UGT genes have been identified ([@B4]). *UGT74S1* gene expression was high in the seed coat. Since SDG accumulates in the seed coat ([@B30]), it was suggested that *UGT74S1* might play a role as SECO GT ([@B4]). Further studies found that two UGT genes, *UGT74S1* and *UGT94H*, exhibited high expression level in the developing seeds, and their expression correlated with that of PLR genes, involved in SECO biosynthesis ([@B29]). However, upon reaction of the purified proteins with SECO and UDP-glucose, only *UGT74S1* produced both SECO monoglucoside (SMG) and SDG metabolites, showing that *UGT74S1* is involved in SECO glycosylation to form flax SDG lignan ([@B29]).

The uniqueness of *UGT74S1* in controlling SDG formation from SECO was further proven in a study characterizing a mutagenized flax population with mutations in *UGT74S1* and altered lignan glycosylation, which showed that the loss-of-function of SECO glycosylation into SDG was attributable solely to *UGT74S1* mutation ([@B21]). UGT74S1 may be the key enzyme controlling SECO glycosylation in flax, although two closely related genes, *UGT74S4* and *UGT74S3*, may also contribute to a minor extent, where they may play a role in supplying SMG as a substrate to *UGT74S1* for the second glycosylation step ([@B20]). Moreover, several studies have shown that specific amino acids within the PSPG motif might play a role ([@B31]; [@B49]; [@B47]). Additionally, [@B28] have shown that Trp^355^ and His^352^ are critical amino acids within the PSPG motif and are determinant for *UGT74S1* glycosylating activity ([@B28]).

A summary of the biosynthesis of SDG is shown in Figure [1](#F1){ref-type="fig"}.
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Health Benefits of Sdg
======================

Various studies on the health effects of flaxseed lignans have shown some potential beneficial effects on human and animal health. The conversion of SDG into mammalian lignans, ENL and END, by the intestinal microflora contributes to the bioavailability of SDG; however, other factors, such as diet, antibiotics, and obesity, also affect the circulating lignan levels in the body ([@B1]). Therefore, different levels of lignan bioactivation are observed owing to variations in these factors.

SDG and its mammalian metabolites have been shown to act as nutraceutical agents against some diseases, such as cancer, diabetes, and heart diseases ([@B84]; [@B34]). Some of these health effects (Table [1](#T1){ref-type="table"}) are discussed in this review.

###### 

Health benefits of secoisolariciresinol diglucoside (SDG) and its metabolites, namely secoisolariciresinol (SECO), enterolactone (ENL), and enterodiol (END).

  Health benefits                      Reference                                                                                            
  ------------------------------------ ---------------------------------------------------------------------------------------------------- --------------------------------
  Effects on cardiovascular system     • decrease in thrombus formation rate                                                                [@B75]; [@B66], [@B67], [@B68]
                                       • decrease in atherosclerosis                                                                        
                                       • reduction of serum and hepatic cholesterol and LDL-cholesterol levels                              [@B65]; [@B72]; [@B24]; [@B19]
                                       • increase in vascular endothelial function                                                          [@B56]
                                       • suppression or slowing of progression and regression of atherosclerosis                            [@B70]
                                       • protective effects in a monocrotaline-induced model of pulmonary arterial hypertension (PAH)       [@B73]
  Antidiabetic activity                • reduction of HbA1C in participants with type 2 diabetes                                            [@B53], [@B52]
                                       • decrease in insulin and leptin concentrations                                                      [@B24]
                                       • delay in the onset of diabetes by 80%                                                              [@B64]
  Anticancer effects                   • reduction of mammary tumor incidence                                                               [@B9]
                                       • reduction of terminal end bud structures in the mammary gland                                      [@B89]; [@B82]
                                       • decrease in the expression of COLO 201 human colon cancer cells in athymic mice                    [@B13]
                                       • decrease in prostate-specific antigen level and cell proliferation                                 [@B16]
                                       • suppression of cancer cell proliferation, migration, and metastasis                                [@B10]; [@B44]
  Effects on mental stress             • reduction of plasma cortisol and small increase in plasma fibrinogen levels during mental stress   [@B78]; [@B34]
                                       • antidepressant-like effect of flaxseed SDG                                                         [@B41]
  Effects on the reproductive system   • reduction of immature ovarian relative weight and delay in puberty                                 [@B34]

Antioxidant Activity of SDG
---------------------------

Some beneficial effects of SDG have been attributed to its antioxidant properties. The ability of SDG to scavenge hydroxyl radicals might contribute to its effects in cancer and lupus nephritis ([@B61]; [@B84]). SDG and its metabolites have been also shown to prevent DNA oxidative damage and lipid peroxidation ([@B37]). The antioxidant activities of SECO, SDG, END, and ENL were shown to be involved in the hypocholesterolemic and antiatherogenic effects ([@B62],[@B63]). Moreover, a recent study comparing flaxseed oil and flaxseed lignan showed that SDG could prevent oxidative stress associated with metabolic syndrome ([@B60]).

Additionally, SDG scavenged radiation-induced HOCl in physiological solutions, and a synthetic SDG (LGM2605) was suggested as a promising attenuator of oxidative stress-induced inflammatory tissue damage ([@B46]).

Effects on the Cardiovascular System
------------------------------------

Chronic heart diseases, caused directly or indirectly by oxidative stress, inflammation, obesity, diabetes, dyslipidemia, and hypertension, are the leading causes of death in developed nations ([@B34]). SDG and its metabolites were reported to exhibit cardiovascular protective effects, where they lowered total cholesterol, LDL-cholesterol (LDL-C), and triglyceride levels and normalized HDL-cholesterol (HDL-C) and glucose metabolism, leading to less cardiovascular complications ([@B97]; [@B94], [@B95]). SDG consumption may protect against the development of chronic diseases, such as cardiovascular diseases ([@B45]; [@B50]; [@B2]).

A recent study on the potential protective effects of SDG in monocrotaline-induced pulmonary arterial hypertension was conducted using male rats. Pretreatment with SDG decreased right ventricular hypertrophy, reactive oxygen species (ROS) levels, lipid peroxidation, catalase, superoxide dismutase, glutathione peroxidase activities, alanine transaminase (ALT), and aspartate transaminase (AST) plasma levels, compared to those in the monocrotaline group. However, cotreatment with SDG did not attenuate ventricular hypertrophy, ALT or AST levels, but decreased ROS levels and catalase and superoxide dismutase activities, compared to those in the monocrotaline group ([@B73]).

Secoisolariciresinol diglucoside, even at very low doses (15 mg/kg), suppressed the development of hypercholesterolemic atherosclerosis by 73%, and this effect was associated with a decrease in serum total cholesterol, LDL-C, and oxidative stress, and an increase in HDL-C levels. Therefore, SDG can prevent or delay the progression of atherosclerosis, and hence prevent coronary artery disease, stroke, and peripheral arterial vascular diseases ([@B70]).

Anticancer Effects
------------------

Secoisolariciresinol diglucoside has been shown to prevent some malignancies, such as breast, lung, and colon cancers, owing to its strong antiproliferative, antioxidant, antiestrogenic, and/or antiangiogenic activities. Additionally, the anticancer activity of SDG was suggested to be associated with inhibition of enzymes involved in carcinogenesis ([@B34]). SDG reduced aberrant crypt multiplicity that may protect against colon cancer ([@B35]), and supplementation of SDG in diet resulted in reduction of the volume, area, and number of tumors ([@B40]). In humans, the protective effects of SDG against cancer have been associated with its capability to affect hormone levels and cancer progression ([@B34]). Furthermore, SDG was considered a chemopreventive agent against malignant mesothelioma owing to its ability to reduce acute asbestos-induced peritoneal inflammation, nitrosative, and oxidative stress ([@B59]).

Several studies showed a correlation between SDG metabolites and breast cancer in women, where the serum levels of intestinal microbial END and ENL showed inverse association with breast cancer ([@B58]; [@B5]; [@B34]). SDG might have the potential to promote early enhancement of mammary gland differentiation, which could protect against breast cancer ([@B82]; [@B2]). However, [@B27] showed that the preventive potential of SDG and its metabolites could be affected by the breast cancer resistance protein (BCRP/ABCG2) ([@B27]).

Secoisolariciresinol diglucoside was suggested to protect against breast cancer owing to its regulation of the expression level of zinc transporters since the concentration of zinc is higher in breast cancer cells than in the normal breast cells ([@B96]). Moreover, studies have shown that the anticancer potential of SDG metabolite, ENL, is related to its ability to suppress the proliferation, migration, and metastasis of cancer cells ([@B10]; [@B44]). A research group of Dr. Thompson (University of Toronto) verified the anticancer activity of SDG, where SDG supplementation in mouse diet resulted in a decrease in the tumor load ([@B77]).

In a clinical trial, the anticancer effects of SDG were studied in 45 premenopausal women with suspicious breast biopsies or who were former breast cancer survivors. SDG lignan (50 mg) was administered daily for a year. Women receiving SDG exhibited less breast precancerous changes, and 80% of them showed a decrease in the levels of Ki-67, a biomarker of cell proliferation ([@B18]).

Additionally, the anticancer effects of a purified flaxseed hydrolysate (PFH), a lignan-rich fraction, were studied. PFH of the cultivar Giza9 (rich in SDG) reduced the expression of the metastasis marker, 1-α, metalloproteinases, and vascular endothelial growth factor, one of the most potent stimulators of angiogenesis, whereas it increased caspase-3-dependent apoptosis, suggesting that it exhibited anticancer activity in a human breast cancer cell line T47D. Dietary intake of Giza9 cultivar-derived PFH resulted in a decrease in the tumor volume and an increase in the expression of caspase-3, suggesting that it exerted anticancer activity in tumor-bearing mice ([@B17]).

Antidiabetic Activity
---------------------

Apart from flaxseed fibers that may affect insulin secretion and plasma glucose homeostasis, studies have shown that SDG-containing nutrients also affect plasma glucose homeostasis ([@B84]). SDG reduced C-reactive protein concentration, which is related to insulin resistance in type 2 diabetes ([@B68]; [@B57]), and decreased the development of diet-induced obesity ([@B24]) and glucosuria ([@B64]). Flax lignan complex decreased the metabolic syndrome composite score in males; however, no effects were observed in females ([@B12]). The antidiabetic activity of SDG was suggested to be related to its antioxidant effects ([@B63]; [@B71]).

Secoisolariciresinol diglucoside treatment reduced the incidence of diabetes by 75% in streptozotocin-induced model of diabetes and by 72% in the Bio-Breed diabetic rat model of diabetes. These effects were associated with a decrease in oxidative stress, as evidenced by the decrease in serum and pancreatic malondialdehyde (MDA) levels. SDG was also shown to delay the development of diabetes in Zucker fatty rat type 2 diabetes model, which was associated with reduction of serum MDA and glycated hemoglobin (A1C) levels ([@B69]). Thus, SDG may have antidiabetic potential, where it can reduce the incidence of type 1 diabetes and delay the development of type 2 diabetes in humans.

Effects on Mental Stress
------------------------

Administration of SDG inhibited stress-induced behavioral changes, whereas treatment with high doses of SDG reversed chronic stress-induced increase in serum corticosterone and adrenocorticotropic hormone (ACTH) levels. Additionally, the effects of SDG on the behaviors of ovariectomized mice might be related to modulation of the neuroendocrine-immune network and neurotrophin factor expression ([@B41]). Three flax cultivars with different contents of alpha-linolenic acid and lignans significantly reduced blood pressure during frustrating cognitive task-induced mental stress in postmenopausal women with vascular diseases. The cultivar with the highest lignan and lowest alpha-linolenic acid contents was associated with the minimum increase in peripheral resistance and plasma fibrinogen levels and the maximum reduction of plasma cortisol levels during mental stress ([@B78]).

Effects on the Reproductive System
----------------------------------

The potential effects of SDG on the reproductive system were studied since lignans were reported to have estrogen agonist or antagonist properties. Flaxseed had no effect on rat pregnancy outcome; however, 10% flaxseed-containing diet lowered the birth weight, compared to that of other treatments. Additionally, it exhibited estrogenic effects, including greater uterine and ovarian relative weights, earlier age and lighter body weight at puberty in female offspring, as well as reduced postnatal weight gain and greater sex gland and prostate relative weights in males. However, 5% flaxseed-containing diet reduced immature ovarian relative weight by 29%, delayed puberty by approximately 5 days, and tended to prolong the diestrus, indicating an antiestrogenic effect. Therefore, flaxseed was shown to affect the development of the reproductive system in offspring; thus, caution should be taken when consuming flaxseed during pregnancy and lactation ([@B83]). Exposure to lignans during lactation reduced the susceptibility to mammary carcinogenesis later in life without adverse effects on selective reproductive indices in dams or offspring ([@B9]).

Conclusion
==========

This review summarized the health beneficial effects of SDG, the most predominant lignan in flaxseed, where it can protect against several diseases, including cardiovascular diseases, cancer, diabetes, and mental stress, and affect the reproductive system. Additionally, we reviewed the biosynthetic pathways of SDG in plants.
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